Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data-Reference-Cited by-同舟云学术

Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data

Published:2021-02-13 Issue:4 Volume:37 Page:609-622
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Freedland Stephen J.¹²,Ke Xuehua³,Lafeuille Marie-Hélène⁴,Romdhani Hela⁴,Kinkead Frederic⁴,Lefebvre Patrick⁴,Petrilla Allison⁵,Pulungan Zul⁵,Kim Seung⁵,D’Andrea Denise M.³,Francis Peter⁶,Ryan Charles J.⁷

Affiliation:

1. Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA

2. Urology Section, Durham VA Medical Center, Durham, NC, USA

3. Janssen Scientific Affairs, LLC, Horsham, PA, USA

4. Analysis Group, Inc, Montreal, Canada

5. Avalere Health, Washington, DC, USA

6. Janssen Pharmaceuticals, Inc, Raritan, NJ, USA

7. Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA

Funder

Janssen Scientific Affairs, LLC

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1879753

Reference42 articles.

1. Treatment of Advanced Prostate Cancer

2. Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model

3. Surveillance, Epidemiology, and End Results Program (SEER). Cancer Stat Facts: Prostate Cancer 2020; [cited 2020 October 19]. Available from: https://seer.cancer.gov/statfacts/html/prost.html.

4. Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer.

5. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting;Journal of Health Economics and Outcomes Research;2024-08-19

2. Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting;Journal of Health Economics and Outcomes Research;2024-08-19

3. Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting;European Urology Oncology;2024-08

4. Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data Linkage;JAMA Network Open;2024-06-14

5. Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer;JCO Precision Oncology;2024-05